Conavi Medical Corp.
CNVIF
$0.33
$0.000.61%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.46M | 3.54M | 3.79M | 4.19M | 1.55M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.46M | 3.54M | 3.79M | 4.19M | 1.55M |
| Cost of Revenue | 485.90K | 788.20K | 1.12M | 1.64M | 1.56M |
| Gross Profit | 2.97M | 2.76M | 2.67M | 2.55M | -6.20K |
| SG&A Expenses | 4.32M | 4.46M | 5.20M | 5.27M | 5.22M |
| Depreciation & Amortization | 578.40K | 609.20K | 624.70K | 670.00K | 716.50K |
| Other Operating Expenses | 94.50K | 153.30K | 153.30K | 153.30K | 140.20K |
| Total Operating Expenses | 16.10M | 17.05M | 20.46M | 21.55M | 21.16M |
| Operating Income | -12.64M | -13.51M | -16.67M | -17.36M | -19.61M |
| Income Before Tax | -13.31M | -20.17M | -27.12M | -30.22M | -31.92M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -13.31 | -20.17 | -27.12 | -30.22 | -31.92 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -13.31M | -20.17M | -27.12M | -30.22M | -31.92M |
| EBIT | -12.64M | -13.51M | -16.67M | -17.36M | -19.61M |
| EBITDA | -12.29M | -13.19M | -16.32M | -16.95M | -19.14M |
| EPS Basic | -0.24 | -2.09 | -3.59 | -4.40 | -5.18 |
| Normalized Basic EPS | -0.21 | -0.88 | -1.62 | -2.11 | -2.57 |
| EPS Diluted | -0.24 | -2.09 | -3.59 | -4.40 | -5.18 |
| Normalized Diluted EPS | -0.21 | -0.88 | -1.62 | -2.11 | -2.57 |
| Average Basic Shares Outstanding | 232.13M | 161.11M | 98.73M | 60.64M | 24.64M |
| Average Diluted Shares Outstanding | 232.13M | 161.11M | 98.73M | 60.64M | 24.64M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |